FDA OKs cervical colposcopic display software

Clint vanSonnenberg | | Health Imaging | Practice Management
The FDA has cleared STI Medical Systems' ImageSense software for visualizing acetowhitening in cervical colposcopic exams.

ImageSense produces a digital output that depicts color differences of the cervix before and after the application of acetic acid during a colposcopic exam. This display digitizes and memorializes acetowhitening to enhance physicians' viewing of the process, the company claimed.

Honolulu-based STI, which produces medical imaging systems and machine vision software as a subsidiary of Science and Technology International, offers ImageSense on its UltraSightHD digital colposcopy system.

Clint vanSonnenberg

Related Content

New protocol addresses contrast allergies in patients with suspected stroke
Do large language models help or hinder workflows related to radiology reports?
Hospital creates 'virtual reality technologist' role to support patients during interventional procedures
Telehealth visits not to blame for uptick in imaging orders, study shows
Up to half of medical organizations either already using or preparing to implement AI
Warning: Sidelined reactor could trigger medical isotope shortage

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.